We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
-$238M
Cap. Flow
-$147M
Cap. Flow %
-12.32%
Top 10 Hldgs %
60.4%
Holding
78
New
16
Increased
22
Reduced
29
Closed
7

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$23.6M
2
HCA icon
HCA Healthcare
HCA
+$14.7M
3
TECH icon
Bio-Techne
TECH
+$12.4M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$11.9M
5
KRYS icon
Krystal Biotech
KRYS
+$10.9M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$42.8M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$36.3M
3
GSK icon
GSK
GSK
+$30.5M
4
NTRA icon
Natera
NTRA
+$20.7M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 77.99%
2 Miscellaneous 20.84%
3 Communication Services 0.66%
4 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
76
Tenet Healthcare
THC
$21.5B
– –
-141,892
Closed -$8.43M
ITCI
77
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-218,726
Closed -$11.8M
HSKA
78
DELISTED
Heska Corp
HSKA
– –
-26,409
Closed -$2.58M
1 2 3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Eversept Partners held 78 positions worth $1.2B, down 17% from $1.43B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Eversept Partners withdrew a net $147M in Q2 2023, closing 7 positions and reducing 29 holdings. Its most notable exit was Biogen, an estimated $42.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 76% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Eversept Partners opened a new position in Inspire Medical Systems worth $26.8M.

  • Eversept Partners's largest Q2 2023 buy was Inspire Medical Systems: 82,445 shares worth $26.8M.
  • Eversept Partners added most to HCA Healthcare in Q2 2023, an estimated $14.7M increase.
  • Eversept Partners's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $36.3M.
  • Eversept Partners fully exited Biogen in Q2 2023, selling an estimated $42.8M.
  • Eversept Partners's ten largest holdings make up 60% of its $1.2B portfolio in Q2 2023.
  • Eversept Partners opened 16 new positions and closed 7 in Q2 2023.
  • Eversept Partners's portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Eversept Partners's 13F filing for Q2 2023, filed 14 Aug 2023.